Hsiang-Lin Tsai

6PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 23, 2023
Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in BRAF-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational Study.

Hsiang-Lin Tsai, Ching-Wen Huang, Yen-Cheng Chen

|Mar 11, 2023
MicroRNAs as Predictive Biomarkers in Patients with Colorectal Cancer Receiving Chemotherapy or Chemoradiotherapy: A Narrative Literature Review.

I-Ping Yang, Kwan-Ling Yip, Yu-Tang Chang

|Jan 16, 2023
Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy.

Yu-Tang Chang, Hsiang-Lin Tsai, Yen-Cheng Chen

|Dec 11, 2022
Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer.

Jen-Pin Chuang, Hsiang-Lin Tsai, Po-Jung Chen

|Jun 24, 2022
Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?

Jen-Hao Yeh, Yung-Sung Yeh, Hsiang-Lin Tsai

|May 28, 2022
Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice.

Kwan-Ling Yip, Tsen-Ni Tsai, I-Ping Yang

Pageof 1

Frequent Collaborators

6 joint publications

Jaw-Yuan Wang

3 joint publications

Tsung-Kun Chang

1 joint publications

Jen-Pin Chuang

1 joint publications

Yu-Tang Chang